SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : XOMA. Bull or Bear?
XOMA 31.88+0.2%Nov 25 3:59 PM EST
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: manfredhasler who wrote (14747)9/19/2000 11:02:18 AM
From: aknahow  Read Replies (3) of 17367
 
Manfred, you do know that the study was blinded, don't you? XOMA did not know in which groups the deaths had occurred nor
other details. The DSMB saw a favorable trend and the FDA mandated necessary mortality target of 34 had not been reached so the study continued. I am not sure how halting in mid trial to make an adjustment works in a well regulated, FDA controlled system. Might work better under a system that used a bit of anarchy and common sense.

Perhaps it would be better to wait until you read the entire article.
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News